In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Warner Chilcott gets US rights to Novartis' Enablex
30 Sep 2010
Novartis AG has granted Warner Chilcott PLC (primarily dermatology, women's health, gastrointestinal, and muscloskeletal conditions) exclusive US marketing rights to Enablex (darifenacin) extended-release tablets for adults with symptoms of an overactive bladder, which include urge urinary incontinence, urgency, and frequency.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?